ACPA currently constitute the most specific serological marker for the diagnosis of RA and have been thereby included in the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2010 RA classification criteria (59). This evidence concerns the gene PRTN3 and rheumatoid arthritis.